M. Morra

Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments

E. Righi, S. Kumar-Singh, E. Tacconelli, 2022, medRxiv.

Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

J. Hasenauer, S. Kumar-Singh, E. Tacconelli, 2022, Biomedicines.